Updated:
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001662244, and its reported...
Overview
Cyteir Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001662244, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-23, it reported net income of USD -46,061,000; total assets of USD 153,232,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Cyteir Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Stoneham, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001662244
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2022USD | -$46.1M | $153.2M | $147.1M | -$42.5M | |
| FY2021USD | -$42.1M | $195.4M | $189.7M | -$36.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| SC 13G | — | Form SC 13G | |
| SC 13D | — | Form SC 13D | |
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Cyteir Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.